Oliver Bisazza Warns That EU’s Innovation Issues May Create More Reliance On Medtech Imports
But There Is Still Plenty Of Research Potential In The EU
Executive Summary
Innovation has been hindered in the EU by the costs and complexities of compliance, including in the medtech sector. Bisazza looks at how high-level, multi-sectoral moves are underway to create a more innovation-friendly environment.